The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions

β-Hydroxybutyl acid (βOHB), the most prevalent type of ketone in the human body, is involved in the pathogenesis of cognitive disorders, especially Alzheimer’s dementia (AD), through a variety of mechanisms, such as enhancing mitochondrial metabolism, regulating signaling molecule, increasing histon...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in pharmacology 2022-02, Vol.62, p.15-22
Main Authors: Wang, Jian-Hong, Guo, Lei, Wang, Su, Yu, Neng-Wei, Guo, Fu-Qiang
Format: Article
Language:English
Subjects:
3-Hydroxybutyric Acid - metabolism
3-Hydroxybutyric Acid - pharmacology
Acetylation
Alzheimer Disease - drug therapy
Alzheimer Disease - metabolism
Amyloid beta-Peptides - metabolism
Cognition
Humans
Mitochondria - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813
cites cdi_FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813
container_end_page 22
container_issue
container_start_page 15
container_title Current opinion in pharmacology
container_volume 62
creator Wang, Jian-Hong
Guo, Lei
Wang, Su
Yu, Neng-Wei
Guo, Fu-Qiang
description β-Hydroxybutyl acid (βOHB), the most prevalent type of ketone in the human body, is involved in the pathogenesis of cognitive disorders, especially Alzheimer’s dementia (AD), through a variety of mechanisms, such as enhancing mitochondrial metabolism, regulating signaling molecule, increasing histone acetylation, affecting the metabolism of Aβ and Tau proteins, inhibiting inflammation and lipid metabolism, and regulating intestinal microbes. Based on the above findings, clinical drug development in AD has begun to focus on βOHB.
doi_str_mv 10.1016/j.coph.2021.10.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2609461555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471489221001582</els_id><sourcerecordid>2609461555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813</originalsourceid><addsrcrecordid>eNp9kM9u1DAQxi1ERUvhBTigHLlk8ThxNpa4oIp_UiUu7dl1xpONV0kcbGfFvhYPwjPVq205cpqZT998mvkx9g74Bjg0H_cb9MuwEVxAFjacyxfsCuotlLXaVi-f-1aJS_Y6xj3nIKtq-4pdVlkEEPUVe7gbqFh8ojk5MxbLYMJk0I9-5zDPE-FgZhenWPi--PunHI42-N_Hbk3HYBIVvQ-Fm5bgD27eFeh3s0vukPV1xuT8HN-wi96Mkd4-1Wt2__XL3c338vbntx83n29LrDlPpbU9CsxvtaJRSrSdIQM91miVNMqCVEaSBOCd7KwABTU00MkW0W4FtlBdsw_n3HzLr5Vi0pOLSONoZvJr1KLhqm5ASpmt4mzF4GMM1OsluMmEowauT2T1Xp_I6hPZk5bJ5qX3T_lrN5H9t_KMMhs-nQ2Uvzw4CjqioxnJukCYtPXuf_mPizyM8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2609461555</pqid></control><display><type>article</type><title>The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions</title><source>ScienceDirect Journals</source><creator>Wang, Jian-Hong ; Guo, Lei ; Wang, Su ; Yu, Neng-Wei ; Guo, Fu-Qiang</creator><creatorcontrib>Wang, Jian-Hong ; Guo, Lei ; Wang, Su ; Yu, Neng-Wei ; Guo, Fu-Qiang</creatorcontrib><description>β-Hydroxybutyl acid (βOHB), the most prevalent type of ketone in the human body, is involved in the pathogenesis of cognitive disorders, especially Alzheimer’s dementia (AD), through a variety of mechanisms, such as enhancing mitochondrial metabolism, regulating signaling molecule, increasing histone acetylation, affecting the metabolism of Aβ and Tau proteins, inhibiting inflammation and lipid metabolism, and regulating intestinal microbes. Based on the above findings, clinical drug development in AD has begun to focus on βOHB.</description><identifier>ISSN: 1471-4892</identifier><identifier>EISSN: 1471-4973</identifier><identifier>DOI: 10.1016/j.coph.2021.10.005</identifier><identifier>PMID: 34891124</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>3-Hydroxybutyric Acid - metabolism ; 3-Hydroxybutyric Acid - pharmacology ; Acetylation ; Alzheimer Disease - drug therapy ; Alzheimer Disease - metabolism ; Amyloid beta-Peptides - metabolism ; Cognition ; Humans ; Mitochondria - metabolism</subject><ispartof>Current opinion in pharmacology, 2022-02, Vol.62, p.15-22</ispartof><rights>2021 The Author(s)</rights><rights>Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813</citedby><cites>FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34891124$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Jian-Hong</creatorcontrib><creatorcontrib>Guo, Lei</creatorcontrib><creatorcontrib>Wang, Su</creatorcontrib><creatorcontrib>Yu, Neng-Wei</creatorcontrib><creatorcontrib>Guo, Fu-Qiang</creatorcontrib><title>The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions</title><title>Current opinion in pharmacology</title><addtitle>Curr Opin Pharmacol</addtitle><description>β-Hydroxybutyl acid (βOHB), the most prevalent type of ketone in the human body, is involved in the pathogenesis of cognitive disorders, especially Alzheimer’s dementia (AD), through a variety of mechanisms, such as enhancing mitochondrial metabolism, regulating signaling molecule, increasing histone acetylation, affecting the metabolism of Aβ and Tau proteins, inhibiting inflammation and lipid metabolism, and regulating intestinal microbes. Based on the above findings, clinical drug development in AD has begun to focus on βOHB.</description><subject>3-Hydroxybutyric Acid - metabolism</subject><subject>3-Hydroxybutyric Acid - pharmacology</subject><subject>Acetylation</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - metabolism</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Cognition</subject><subject>Humans</subject><subject>Mitochondria - metabolism</subject><issn>1471-4892</issn><issn>1471-4973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM9u1DAQxi1ERUvhBTigHLlk8ThxNpa4oIp_UiUu7dl1xpONV0kcbGfFvhYPwjPVq205cpqZT998mvkx9g74Bjg0H_cb9MuwEVxAFjacyxfsCuotlLXaVi-f-1aJS_Y6xj3nIKtq-4pdVlkEEPUVe7gbqFh8ojk5MxbLYMJk0I9-5zDPE-FgZhenWPi--PunHI42-N_Hbk3HYBIVvQ-Fm5bgD27eFeh3s0vukPV1xuT8HN-wi96Mkd4-1Wt2__XL3c338vbntx83n29LrDlPpbU9CsxvtaJRSrSdIQM91miVNMqCVEaSBOCd7KwABTU00MkW0W4FtlBdsw_n3HzLr5Vi0pOLSONoZvJr1KLhqm5ASpmt4mzF4GMM1OsluMmEowauT2T1Xp_I6hPZk5bJ5qX3T_lrN5H9t_KMMhs-nQ2Uvzw4CjqioxnJukCYtPXuf_mPizyM8Q</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Wang, Jian-Hong</creator><creator>Guo, Lei</creator><creator>Wang, Su</creator><creator>Yu, Neng-Wei</creator><creator>Guo, Fu-Qiang</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202202</creationdate><title>The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions</title><author>Wang, Jian-Hong ; Guo, Lei ; Wang, Su ; Yu, Neng-Wei ; Guo, Fu-Qiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3-Hydroxybutyric Acid - metabolism</topic><topic>3-Hydroxybutyric Acid - pharmacology</topic><topic>Acetylation</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - metabolism</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Cognition</topic><topic>Humans</topic><topic>Mitochondria - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Jian-Hong</creatorcontrib><creatorcontrib>Guo, Lei</creatorcontrib><creatorcontrib>Wang, Su</creatorcontrib><creatorcontrib>Yu, Neng-Wei</creatorcontrib><creatorcontrib>Guo, Fu-Qiang</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Jian-Hong</au><au>Guo, Lei</au><au>Wang, Su</au><au>Yu, Neng-Wei</au><au>Guo, Fu-Qiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions</atitle><jtitle>Current opinion in pharmacology</jtitle><addtitle>Curr Opin Pharmacol</addtitle><date>2022-02</date><risdate>2022</risdate><volume>62</volume><spage>15</spage><epage>22</epage><pages>15-22</pages><issn>1471-4892</issn><eissn>1471-4973</eissn><abstract>β-Hydroxybutyl acid (βOHB), the most prevalent type of ketone in the human body, is involved in the pathogenesis of cognitive disorders, especially Alzheimer’s dementia (AD), through a variety of mechanisms, such as enhancing mitochondrial metabolism, regulating signaling molecule, increasing histone acetylation, affecting the metabolism of Aβ and Tau proteins, inhibiting inflammation and lipid metabolism, and regulating intestinal microbes. Based on the above findings, clinical drug development in AD has begun to focus on βOHB.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34891124</pmid><doi>10.1016/j.coph.2021.10.005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-4892
ispartof Current opinion in pharmacology, 2022-02, Vol.62, p.15-22
issn 1471-4892
1471-4973
language eng
recordid cdi_proquest_miscellaneous_2609461555
source ScienceDirect Journals
subjects 3-Hydroxybutyric Acid - metabolism
3-Hydroxybutyric Acid - pharmacology
Acetylation
Alzheimer Disease - drug therapy
Alzheimer Disease - metabolism
Amyloid beta-Peptides - metabolism
Cognition
Humans
Mitochondria - metabolism
title The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20potential%20pharmacological%20mechanisms%20of%20%CE%B2-hydroxybutyrate%20for%20improving%20cognitive%20functions&rft.jtitle=Current%20opinion%20in%20pharmacology&rft.au=Wang,%20Jian-Hong&rft.date=2022-02&rft.volume=62&rft.spage=15&rft.epage=22&rft.pages=15-22&rft.issn=1471-4892&rft.eissn=1471-4973&rft_id=info:doi/10.1016/j.coph.2021.10.005&rft_dat=%3Cproquest_cross%3E2609461555%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-ddfc2c1018269928baea1fc4cd95a9d159a5e5110b5bd21914161b58ccd72c813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2609461555&rft_id=info:pmid/34891124&rfr_iscdi=true